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Abstract 
1. We iontophoretically applied NG-nitro-L-arginine (L-NOArg), an inhibitor of nitric oxide synthase (NOS), to cells 
(n= 77) in area 17 of anaesthetized and paralysed cats while recording single-unit activity extracellularly. In 
twenty-nine out of seventy-seven cells (38%), compounds altering NO levels affected visual responses. 
2. In twenty-five out of twenty-nine cells, L-NOArg non-selectively reduced visually elicited responses and 
spontaneous activity. These effects were reversed by co-application of L-arginine (L-Arg), which was without 
effect when applied alone. Application of the NO donor diethylamine-nitric oxide (DEA-NO) produced excitation 
in three out of eleven cells, all three cells showing suppression by L-NOArg. In ten cells the effect of the soluble 
analogue of cGMP, 8-bromo-cGMP, was tested. In three of those in which L-NOArg application reduced firing, 
8-bromo-cGMP had an excitatory effect. In six out of fifteen cells tested, L-NOArg non-selectively reduced 
responses to NMDA and α-amino-3-hydroxy-5-methylisoxasole-4-propionic acid (AMPA). Again, co-application 
of L-Arg reversed this effect, without enhancing activity beyond control values. 
3. In a further subpopulation of ten cells, L-NOArg decreased responses to ACh in five. 
4. In four out of twenty-nine cells L-NOArg produced the opposite effect and increased visual responses. This was 
reversed by co-application of L-Arg. Some cells were also affected by 8-bromo-cGMP and DEA-NO in ways 
opposite to those described above. It is possible that the variety of effects seen here could also reflect trans-
synaptic activation, or changes in local circuit activity. However, the most parsimonious explanation for our data 
is that NO differentially affects the activity of two populations of cortical cells, in the main causing a non-specific 
excitation. 
The recent explosion of interest surrounding the gaseous ‘neurotransmitter’ nitric oxide (NO) has 
covered many fields within neurobiology in general (for reviews see Garthwaite, 1991; Moncada, Palmer 
& Higgs, 1991; Snyder & Bredt, 1991; Schuman & Madison, 1994; Zhang & Snyder, 1995), while 
reports in sensory neurobiology are much rarer. In contrast to traditional neurotransmitters, NO is a freely 
diffusible gaseous molecule released in the neuropil of the CNS, and offers a novel route of 
communication between neurons, glia and even blood vessels (Ignarro, Buga, Woods, Byrns & 
Chaudhuri, 1987; Palmer, Ferrige & Moncada, 1987), possibly having a potent influence remote from its 
site of production by stimulating soluble guanylate cyclase, leading to an increase in intracellular cGMP 
in target cells (Garthwaite, 1991; Wood & Garthwaite, 1994). NO has been shown to be produced by the 
enzyme nitric oxide synthase (NOS) in a Ca2+-dependent process, utilizing the endogenous amino acid L-
arginine as its substrate (Knowles, Palacios, Palmer & Moncada, 1989; Bredt & Snyder, 1990). We have 
recently demonstrated that within the dorsal lateral geniculate nucleus (dLGN) of the thalamus of the cat, 
NO acts to selectively enhance responses mediated via the NMDA receptor, thereby facilitating the 
transfer of the visual information that utilizes this excitatory amino acid receptor type (Cudeiro, Grieve, 
Rivadulla, Rodriguez, Martinez-Conde & Acuña, 1994a; Cudeiro, Rivadulla, Rodriguez, Martinez-
Conde, Acuña & Alonso, 1994b; Cudeiro, Rivadulla, Rodriguez, Martinez-Conde, Grieve & Acuña, 
1996). This effect was not mimicked by application of the second messenger cGMP, in the water-soluble 
8-bromo-cGMP form (Cudeiro et al. 1994a). Such a mechanism is intriguing, given that at this location 
the sole source of NOS has been shown to be fibres arising from the parabrachial region of the brainstem, 
where NOS is co-localized with ACh (Bickford, Günlük, Guido & Sherman, 1993). In the cerebral cortex, 
however, NO production may arise from several possible sources: extrinsically from cholinergic fibres 
arising in the nucleus basalis of the forebrain (Bickford, Günlük, Van Horn & Sherman, 1994); 
intrinsically from cells within the cortex which contain NOS (a subset of the non-spiny cortical neurons) 
(Bredt, Hwang & Snyder, 1990; Dawson, Bredt, Fotuhi, Hwang & Snyder, 1991; Kuchiiwa, Kuchiiwa, 
Mori & Nakagawa, 1994); or even from cortical blood vessels that are capable of NO production from the 
endothelial cells of the vessel walls (Bredt et al. 1990; for review see Iadecola, 1993). Such a diversity of 
production sites suggests a more complex role in cortical visual processing than we have previously 
demonstrated in the thalamus. For example, recent evidence has shown that NO may be involved in the 
NMDA-mediated release of noradrenaline and glutamate from rat cortical synaptosomes, suggesting that 
NO can have both direct actions and actions on modulatory processes (Montague, Guancayco, Winn, 
Marchase & riedlander, 1994). Of course, since the release of these compounds was specific to NMDA, 
the effects of NO on other excitatory amino acid receptor-mediated events remain untested. Nevertheless, 
there is to date little or no published evidence on the effect of NO, or the effect of blockade of NOS, on 
visual cortical cells. We have therefore examined such effects using microiontophoresis of a competitive 
inhibitor of NOS, NG-nitro-L-arginine (l-NOArg) and a NO donor, diethylamine-nitric oxide (DEA-NO). 
Specifically, we have sought to determine what role, if any, NO may have in the elaboration of cortical 
visual properties, as well as addressing the possibility of more global effects on cell excitability. 
Furthermore, given our previous findings on the mode of action of NO within the dLGN, where it 
selectively enhanced NMDA receptor-mediated activity, we have investigated whether such receptor 
specificity is involved in any cortical locus of action. A preliminary report of these data has been 
published (Cudeiro, Bivadulla, Rodriguez, Martinez-Conde & Acuña, 1995). 
Methods 
Experiments were carried out on nineteen adult cats in the weight range 1.8–2.5kg. Animals were 
anaesthetized with halothane (0.1–5%) in nitrous oxide (70%) and oxygen (30%), and paralysed with 
gallamine triethiodide (40 mg initial dose, then 10 mg kg−1 h−1). EEG and ECG, expired CO2 and 
temperature were monitored and maintained continuously, to ensure that anaesthetic levels were altered 
as appropriate to maintain an adequate state of light anaesthesia. Changes in parameters indicating a 
lightening of anaesthetic levels (e.g. changes in intersystolic interval, decreasing spindle frequency, rise in 
end-tidal CO2) were immediately counteracted by increasing halothane levels accordingly. Once a stable 
baseline level had been established any variation in the parameters monitored triggered an alarm system. 
Lignocaine (lidocaine) gel was applied to the ear bars of the stereotaxic frame and all wound margins 
were treated with subcutaneus injections of lignocaine and adrenaline. Further details of surgical 
procedures and maintenance can be found in Cudeiro & Sillito (1996). 
Single units were recorded extracellularly from primary visual cortex (Horsley—Clarke coordinates: 
anteroposterior, –2 to –8 mm relative to interauricular line; mediolateral, +0.6 to +1.5 mm relative to mid-
line) using seven barrelled glass micropipettes. Pipettes were filled with a combination of the following 
drugs: NaCl (3 M for extracellular recording); L-arginine (L-Arg; 10 mM, pH 6.0); N
G-nitro-L-arginine (l-
NOArg; 10 mM, pH 6.0); N-methyl-D-aspartate (NMDA; 0.1 M, pH 8.0); α-amino-3-hydroxy-5-
methylisoxasole-4-propionic acid (AMPA; 15 mM, pH 8); ACh (0.5M, pH 4.0); diethylamine-nitric oxide 
(DEA-NO; 10 mM, pH 8.0); 8-bromo-cGMP (10 nm, pH 4.5); and Pontamine Sky Blue (PSB; 2% w/v in 
0.5 M sodium acetate solution for histological reconstruction applied at 20–40 μA for 15–20 min). All 
drugs were purchased from Sigma and RBI. Pipette tips were broken back to diameters ranging from 3–
10 μm, and when not in use each drug barrel was subject to a constant retention current of 5–25 nA of 
appropriate polarity. 
Pipettes were inserted in a plane nearly perpendicular to the cortical surface and cells were recorded 
throughout the depth of the visual cortex. All neurons had visual fields centered within 10 deg of the area 
centralis. 
Single units were classified into simple and complex types by virtue of their responses to drifting fight 
and dark edges (Henry 1977). Single-unit data were collected, and visual stimuli produced, under 
computer control (Visual Stimulation System, Cambridge Electronic Design, Cambridge, UK; for details 
see Sillito, Cudeiro & Murphy, 1993). Stimuli were viewed monocularly through the dominant eye for 
each cell under test. The eyes were treated with atropine methonitrate and phenylephrine hydrochloride, 
and protected with plastic contact lenses. They were brought to focus on a semi-opaque tangent screen at 
a distance of 0.57 m using supplementary lenses and 2 mm diameter artificial pupils. 
Our basic protocol was to establish control responses to a drifting bar stimulus, moving backwards 
and forwards through the receptive field, at the optimal orientation. Subsequently, this procedure was 
repeated in the presence of the compound or compounds of interest. We also examined the effects of the 
drugs on spontaneous activity, and in some cases during a complete set of orientations of the moving bar, 
in which presentation of stimuli of different orientations was randomized. Typically, responses were 
averaged over ten to twenty stimulus presentations and were assessed from the accumulated count in the 
binned peristimulus time histograms (PSTHs), using separate epochs for baseline and visual responses. A 
change in firing was considered significant when P < 0.05 (Wilcoxon signed-rank test). Where error bars 
are shown these are ±1 s.e.m. 
To examine the nature of the action of NOS inhibitors on excitatory responses evoked by exogenously 
applied NMDA, AMPA or ACh, we used pulsatile iontophoretic application of the excitant before and 
during continuous application of L-NOArg (alone or in combination with L-Arg). The effect of 
iontophoretic ejection of 8-bromo-cGMP on visually driven activity was also tested. The magnitude of the 
drug iontophoretic application current was selected on the basis of initial qualitative observations. Effects 
were generally seen within the range 60–120 nA and no ejection current above this range was used. At the 
end of each experiment, the animals were killed by anaesthetic overdose and the locations of the 
recording sites were determined in Nissl-stained sections from PSB deposits made at the sites of interest. 
All procedures were carried out in accordance with Spanish National Guidelines, the International 
Council for Laboratory Animal Science and the European Union (86/809). 
Results 
This report is based on data obtained from a sample of seventy-seven cells located throughout the 
depth of the primary visual cortex. On the basis of their responses to L-NOArg application we have 
divided this population into two groups, with clear responses to this compound in one group, and no 
effect in the other. However, no other visual response property clearly belonged to one group or the other. 
There was therefore no relationship between the actions of the compounds applied that modulated the 
nitric oxide system and the receptive field type, layer and degree of direction or orientation selectivity. 
Twenty-nine out of seventy-seven cells were affected by iontophoretic application of L-NOArg. As 
shown in Fig. 1, the major effect of L-NOArg was suppressive (25/29). Here the responses of a non-
directionally selective complex cell located in layers II–III (Fig. 1A) were markedly reduced (∼60%) by 
continuous application of L-NOArg (Fig. 1B), along with a suppression of background firing (see below). 
Effects were manifest within 3–4 min of application and had offset times in the range 6–10 min. 
Responses to both directions of stimulus motion were equally depressed.  
 
 
 
Figure 1 The suppressive effect of NOS inhibition on visual responses 
Peristimulus time histograms (PSTHs) of the responses of a non-directionally selective complex cell. A shows the control responses 
to an optimally oriented bar of light moved backwards and forwards across the receptive field (here and in subsequent figures shown 
as an inset above the PSTHs). In B these responses were repeated during constant application of L-NOArg, and in C with both l-
NOArg and L-Arg. Finally in D the test was repeated in the presence of L-Arg alone. In all cases where responses to L-Arg alone 
were compared with its effect on the l-NOArg effect, the same application current was used. Each PSTH is the mean of 15 trials, 
and bin width is 100 ms. 
However, co-application of L-Arg completely reversed this L-NOArg-induced inhibition (Fig. 1C). 
Application of L-Arg alone (Fig. 1D), even at current levels exceeding those required to block or reverse 
the L-NOArg effect (data not shown), did not increase response levels above the control levels shown in 
Fig. 1A. In cells showing measurable spontaneous activity (14/25), this activity was also reduced during 
drug application, as illustrated in Fig. 2. Here, the spontaneous activity of a simple cell in layer V is 
shown to be reduced by some 84%. In terms of visual responses, the effect of L-NOArg application was 
rapid, reaching peak effectiveness within a few minutes (Fig. 2B). Again co-application of the substrate 
for NOS, L-Arg, reversed the inhibitory effects of L-NOArg, but without measurably increasing 
spontaneous activity (Fig. 2C).  
 
Figure 2 The suppressive effect of NOS inhibition on spontaneous activity 
A, PSTHs showing the spontaneous activity of one of the visual cortical cells with demonstrable activity (n= 14). In B, the effect of 
continuous application of L-NOArg is shown, with the suppression of such an effect with concurrent L-NOArg and L-Arg shown in 
C. Each PSTH is the mean of 10 trials, and bin width is 1s. 
A second example of the inhibitory effect of L-NOArg application on visual responses is illustrated in 
Fig. 3, where a simple cell in layer IV is shown. In this case we have illustrated (Fig. 3A) a full control 
orientation tuning curve, with data points taken at 30 deg of visual angle intervals around 360 deg. This 
clearly highly orientation- and direction-selective cell, with little or no spontaneous activity, was heavily 
suppressed by application of L-NOArg (Fig. 3A, dashed line) with responses at all orientations and 
directions being affected. The responses to the optimal orientation are shown in detail in the PSTHs on 
the right (Fig. 3C). Once again co-application of l-Arg prevented the effect of the NOS inhibitor (Fig. 
3B). This suppression of visual response and decreased spontaneous activity due to application of L-
NOArg and the reversal of these effects by L-Arg co-application was common to all twenty-five cells. On 
average, in this group visual responses were reduced by 62 ± 4 % (means ±s.e.m., P < 0.001), and 
spontaneous activity by 56 ± 9% (P < 0.001).  
 
 
 
Figure 3 NOS inhibition reduces visual responsiveness but not specificity 
A, graphic representation of the orientation tuning of a layer IV simple cell (continuous line, control; dashed line, during L-NOArg 
application with 80 nA). B, effect of co-application of L-NOArg with L-Arg (continuous line, control; dashed line, L-NOArg +L-Arg 
with 80 nA). Orientation tuning curves as in A. Stimuli were presented randomly interleaved at 30 deg intervals, and were each 
repeated 20 times. C, representative PSTHs showing the responses at the optimal orientation for this directionally selective cell 
before, during L-NOArg application alone and during L-NOArg and L-Arg co-application. 
In eleven cells the effect of the NO donor DEA-NO was also tested. As typified by the example in 
Fig. 4, in three cells visual responses (control PSTH, Fig. 4A) were enhanced by application of DEA-NO 
(Fig. 4B) with, for comparison, the uppression induced by L-NOArg illustrated in Fg. 4D. All three cells 
showed such enhanced responses (mean, 84 ± 19%) and where present, spontaneous activity was also 
elevated. Response selectivity, for example, direction specificity, was unaffected when the response 
magnitude was maintained within subsaturation levels.  
 
 
 
Figure 4 NO enhances visual responses 
PSTHs demonstrating the excitatory effect of DEA-NO on the visual responses of a directionally selective complex cell in layer VI. 
A, control responses; B, enhanced responses during continuous application of 80 nA of DBA-NO; C, recovery; D, decreased 
responses during continuous application of L-NOArg with 80 nA. Bin width, 100 ms; 10 trials. 
In a subpopulation of ten cells, application of L-NOArg was inhibitory, as above, in three. In these three, 
application of the soluble analogue of cGMP, 8-bromo-cGMP, induced excitation. This is illustrated in 
Fig. 5. Once again L-Arg alone was unable to elevate firing rates above control levels, while 8-bromo-
cGMP clearly did so (mean, 106 ± 37%) (Fig. 5D). 
 
 
 
Figure 5 The soluble analogue of cGMP acts like NO 
PSTHs from a simple cell in layer VI. A, control visual responses; B, depression during L-NOArg application; C, recovery; D, effect 
of 8-bromo-cGMP application; E, recovery; F, L-Arg application alone; and G, L-NOArg and L-Arg together. Each PSTH is the 
mean of 10 trials, and bin width is 100 ms.  
With regard to the pharmacological specificity of these effects, Fig. 6 shows a typical example taken 
from a sub-population of six (out of 15) cells tested with application of each of the excitatory amino acids 
NMDA and AMPA. This figure shows clearly that the very potent inhibitory effect of L-NOArg is not 
selective between these two amino acids, reducing the response to each to near zero, and this effect was 
seen in all six cells, differing only quantitatively across the population. Again, the inhibitory effect was 
reversed by co-application of L-Arg (bottom PSTHs in Fig. 6). 
 
 
 
Figure 6 Non-specific reduction of excitatory amino acid responses during NOS inhibition 
PSTHs from a complex cell in layer V. Left columns, activity during application of the excitatory amino acid NMDA, before and 
during continuous application of L-NOArg, and combined application of L-NOArg and L-Arg (each applied with 80 nA). The right 
column shows similar data from the same cell treated in this case with the excitant AMPA. Each PSTH is the mean of 5 trials, bin 
size 1s. The timing and duration of application of the excitant is shown by the bar symbol over each PSTH. 
In ten cells we tested the action of L-NOArg on the effectiveness of the non-amino acid excitant, ACh. 
In five of these cells, responses were heavily suppressed (in each of these five cells, visual responses were 
also affected, while in the remaining five neither visual nor ACh-mediated effects were altered), and this 
effect was reversed by concurrent application of l-Arg. This is illustrated by the PSTHs in Fig. 1A, with 
effects on visual responses shows in Fig. 1B. The histogram in Fig. 1C summarizes the effectiveness of 
NOS inhibition for the population of five cells. It is again striking that the L-NOArg-induced suppression 
was effectively blocked by L-Arg, which itself did not elevate activity. 
As mentioned above, in twenty-five out of twenty-nine cells affected by L-NOArg, visual responses 
were suppressed. However, in the remaining four (2 complex cells and 2 simple cells), the effect of L-
NOArg was exactly the opposite–it induced a significant increase in the magnitude of the visual responses 
in each of these cells (58 ± 13%). In the example in Fig. 8B, the visual responses during L-NOArg 
application are greatly enhanced compared with control values (Fig. 8A) yet, as shown in Fig. 8E, 
responses during the combined application of both L-NOArg and L-Arg are equal to control values. In two 
of the five cells (out of a total of eleven) affected by DPA-NO application (see above), responses were 
reduced by some 43%, again showing an effect opposite to that of the larger population of cells affected 
by L-NOArg. Although few in number, these cells were extremely striking in the difference in their 
responses to these drugs, a difference that was clearly reproducible and that remained unchanged for as 
long as the recordings of these cells could be maintained. These cells are also exemplified by the cell 
illustrated in Fig. 8F, where DEA-NO application resulted in a clear suppression of the visual responses. 
 
 
 
Figure 8 Excitatory effect of NOS inhibition on 5% of the cell population 
Here the visual responses shown in the PSTHs in B are significantly enhanced above control levels, shown in A. D is the recovery 
PSTH shown in C, but note the redrawn scale. The relative lack of enhancement when L-NOArg and L-Arg are co-applied (E), and 
the depressive effect of DEA-NO (F) are compared. Each PSTH is the mean of 10 trials, and bin width is 100 ms. 
In summary, Fig. 9 illustrates the laminar distribution of the cells affected and unaffected by L-NOArg 
as outlined above, broken down by cell type (see Fig. 9 legend). We could find no significant correlation 
between cell type or lamina and the effectiveness of L-NOArg. 
 
 
 
 
 
 
 
 
 
 
Figure 9 Diagrammatic summary of the distribution of cell populations affected or unaffected by l-NOArg throughout the 
depth of area 17 
★, cells unaffected by L-NOArg (n= 48; 22 simple cells and 26 complex). •, cells with activities reduced by L-NOArg (n= 25; 10 
simple and 15 complex). +, cells with activity increased by L-NOArg (n= 4; 2 simple and 2 complex). The cells are shown projected 
onto a line drawing of a representative section of the histological reconstruction from one experiment The relevant full section is 
shown in the inset. The mediolateral position of the cells is arbitrary. 
Discussion 
Based both on our previous work and that of other groups (Cudeiro et al. 1994a,b, 1995, 1996; Kara 
& Friedlander, 1995), we are confident that our iontophoretic application of l-NOArg produces effective 
local inhibition of the enzyme NOS, thereby preventing release of NO, and we believe that the activity we 
see does not rely on other transmitter substances or pathways in the cortex, but represents the action of a 
tightly bound, slowly dissociating competitive antagonist at the l-Arg site of NOS (Furfine, Harmon, 
Paith & Garvey, 1993; Klatt, Schmidt, Brunner & Mayer, 1994). By far the most potent effect of NOS 
inhibition we have seen is a depression of activity, both visually elicited and spontaneous. This effect is 
typical of our previous findings in the dLGN, where all cells encountered, of all cell types, showed just 
such a suppression during NOS inhibition. However, it is interesting to note that the majority of our 
population of seventy-seven cortical cells, some forty-eight, were completely unaffected by inhibition of 
NOS, and, moreover, unresponsive to the application of NO via the donor DEA-NO. It has previously 
been suggested that locally produced NO (such as that produced by DEA-NO) may affect cells within a 
volume of tissue in the order of 200μm in diameter (Wood & Garthwaite, 1994). Thus cells without 
apparent responses to the application of l-NOArg would seem to lack the biochemical machinery 
necessary to respond to NO manipulating agents, rather than simply being outside of the ‘reach’ of the 
applied compounds. Indeed, cells both responsive and unresponsive to these compounds were found in 
the same electrode penetrations and there was no obvious grouping of the two cell types within individual 
tracks. This suggests a degree of ‘parcellation’ of cortical cells along an as yet undefined axis, but it is 
interesting in this context to note that cat cortex has recently been shown to contain cytochrome oxidase 
blobs (Murphy, Jones & Van Sluyters, 1995), the feature which first began the parcellation of primate 
cortex into regions more complex than orientation and ocular dominance columns (Wong-Riley, 1979; 
Horton & Hubel, 1981). In primate layer VI, the distribution of NADPH, a marker for neuronal NOS, is 
closely aligned with that of cytochrome oxidase, showing a similar laminar and spatial distribution 
(Sandell, 1988), and it is therefore possible that a larger and more detailed sampling of cells in a study 
such as ours may reveal an anatomical correlation of responsiveness to NO-modulating compounds and a 
cortical biochemical marker. 
While it is known that the input from the basal forebrain to the cerebral cortex utilizes ACh as a 
primary neurotransmitter (Bickford et al. 1994), less is known about the nature of the cortical 
postsynaptic recipient structures. It has been suggested that the forebrain selectively influences target 
inhibitory interneurones in the cortex (Beaulieu & Somogyi, 1991) and such intracortical inhibitory 
influences have been proposed to ‘sharpen’ visual receptive field properties (Sillito, 1975, 1977; Eysel, 
Worgotter & Pape, 1987; Ramoa, Paradise & Freeman, 1988). Indeed, the cholinerigic influence itself, 
mediated mainly by cholinergic muscarinic receptors, is known to enhance visual responsivity and 
modulate receptive field properties (Sillito & Kemp, 1983; Murphy & Sillito, 1991). We therefore 
propose that an added NO-mediated influence may extend this direct influence to the neighbouring cells 
within a selected cortical region by diffusion and activation of NO-mediated excitation, as we have 
demonstrated at the single–unit level above. 
In the cortex the mode of action of NO is clearly different to our findings in the thalamus in a number 
of ways. Firstly, in the visual thalamus (LGN and perigeniculate nucleus), all cells encountered were 
affected by NOS blockade (Cudeiro et al. 1994a, b, 1996; Rivadulla, Rodriguez, Martinez-Conde, Acuña 
& Cudeiro, 1996), while in the cortex only some 38% were affected. Furthermore, our NOS blockade in 
the cortex depressed equally the NMDA receptor-mediated excitation and that induced by the non-
NMDA-mediated AMPA receptors and ACh receptors in those cells affected by l-NOArg, while in the 
thalamus, cells were affected by NOS blockade by a mechanism selectively acting via NMDA receptor 
activation (Cudeiro et al. 1994a, b, 1996). The reduction in efficacy of these excitants during NOS 
blockade was lifted when l-Arg was co-applied both in the cortex and in the thalamus, and this was also 
the case for visual responses and spontaneous activity. This is in contrast to the findings of Montague et 
al. (1994) who suggested, from observations on rat cortical synaptosomes, that one action of NO was to 
augment glutamate or noradrenaline release, presumably from neighbouring synapses, as a result of 
NMDA receptor activation. Such a specific presynaptic mode of action seems unlikely to account for the 
straightforward reduction in NMDA-, AMPA- and ACh-mediated visual and spontaneous activity we 
have seen here in vivo. Indeed our findings with 8-bromo-cGMP suggest a simple modulation of the 
cGMP secondary messenger system, again in contrast to our findings in the thalamus. Such an action on 
cGMP has been widely reported in the literature (for reviews see Garthwaite, 1991; Moncada et al. 1991; 
Snyder & Bredt, 1991; Schuman & Madison, 1994; Zhang & Snyder, 1995). We therefore suggest that 
for this population of cortical cells, during normal functioning, NO acts to enhance excitability in a global 
way, perhaps dealing with state-dependent changes in excitability, a role already ascribed to the 
ascending cholinergic fibres arising from the basal forebrain (Buzsáki, Bickford, Ponomareff, Thai, 
Mandel & Gage, 1988; Bickford et al. 1994). This seems to follow logically from the presence of NOS in 
these fibres, co-localized with ACh (Bickford et al. 1994). The ability of co-applied l-Arg to reverse the 
effects of NOS blockade, while alone producing no excitation, mimics the effects we have reported in the 
dLGN (Cudeiro et al. 1994a,b, 1996). 
From these observations we suggest that in this situation, available NOS is a rate-limiting step such 
that increased levels of l-Arg above those which can be immediately processed by the enzyme are without 
effect. We further speculate that the Ca2+-dependent nature of this enzyme and its location in synaptic 
terminals suggests that available enzyme levels may fluctuate with the spiking activity of such terminals, 
‘following’ the activation of the forebrain input to the cortex. The proportion of cells which were not 
responsive to manipulation of the NO system may of course be an underestimate in that, although it has 
been postulated that NO may diffuse over large distances to act on remote sites (Garthwaite, 1991; Wood 
& Garthwaite, 1994), many cells in the visual cortex have dendritic arbours many times greater than the 
NO diffusion range (Martin & Whitteridge, 1984; Wood & Garthwaite, 1994). As a consequence, an 
effect of NO on remote dendrites remains possible, and cannot at this stage be discounted. Whether or not 
such an effect exists does not, however, detract from the hypothesis that, under the conditions with which 
we have investigated the NO system, many cells seem to be unaffected. 
It should be remembered that there are multiple sources of NOS in cat cortex, including some spine-
free cells, presumably GABAergic and inhibitory (Bredt et al. 1990; Dawson et al. 1991). This may 
account for the smaller proportion of cells reported above in which the effects of l-NOArg and DEA-NO 
were the reverse of the majority of cells affected by l-NOArg – essentially suggesting a physiological 
inhibitory role for NO in these cells. However, it is true that many other hypotheses may account for this 
effect, and the extracellular recording technique does not allow identification of the 
morphological/neurotransmitter cell type under study. Indeed, the variety of effects we have seen during 
iontophoretic drug application could result from trans-synaptic activation and/or changes in the activity of 
local circuits. This is particularly relevant to applications of compounds that release NO, which is known 
to be highly diffusable (Wood & Garthwaite, 1994) and will be the subject of future studies. While 
changes in local perfusion might also account for some of the effects reported here, we believe this to be 
unlikely in the anaesthetized and paralysed preparation used here. 
In summary, we have demonstrated not only that a significant proportion, some 38%, of our sample of 
cortical cells is affected by the application of drugs capable of altering NO levels (showing reductions in 
visual responses when NO production is decreased), but also that there exists a small but significant 
proportion of affected cells (5%) whose visual responses are inhibited by NO, suggesting the existence of 
both an up- and down-regulation of cellular firing in separate subpopulations of cortical cells. Finally, our 
results suggest that, unlike in the visual thalamus, this regulation is carried out via the cGMP second 
messenger system. 
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